Condition: Prostate Cancer · Sponsor: State University of New York at Buffalo
This is a a pilot study to assess the feasibility of intermittent caloric restriction (plus a plant-enriched diet optionally) in prostate cancer patients receiving androgen deprivation therapy. Study feasibility measures will include enrollment rate, drop-out rate and compliance with diet measured by self-reports.
This description comes directly from the study's public registry record.
Roberto Pili, MD · 716-881-8918 · rpili@buffalo.edu
Kyle Pasquariello · 716-529-6470 · KPasquariello@gppconline.com
Always discuss trial participation with your own doctor first.
| University at Buffalo/Great Lakes Cancer Center | Buffalo, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06172283